go.Gut Health
Observer
A closer look at the microbiome ↗
Sleep & Stress / EVIDENCE GUIDE

Ashwagandha, Stomach Upset, and Liver Safety: A Practical Guide

Ashwagandha may cause stomach upset, diarrhea, or vomiting, and rare liver injury reports matter. Review trial limits, interactions, and warning signs.

Withania somnifera , developing fruit, the latter a globose berry, bright red when ripe and enclosed by the inflated calyx; Manie van der Schijff Botanical Garden, University of Pretoria, Pretoria, Gauteng, South Africa
Withania somnifera 1DS-II 3-7469 · SAplants · CC BY-SA 4.0 · Source · License
THE KEY TAKEAWAY

Short-term trials can look reassuring while rare liver injury and gastrointestinal intolerance remain relevant to individual decisions.

Why safety is harder to summarize than efficacy

Ashwagandha products are marketed for stress, sleep, exercise, testosterone, and general resilience. They may contain root, leaf, or both, and extracts can be standardized to different withanolide concentrations. A safety result for one standardized root extract cannot automatically cover every formula sold under the plant name.

The National Center for Complementary and Integrative Health says ashwagandha may be safe for short-term use, up to about three months, but there is not enough information to draw conclusions about long-term safety. It lists drowsiness, stomach upset, diarrhea, and vomiting as possible effects.

That time boundary matters. Many users take stress or sleep supplements continuously, while controlled trials often last six to twelve weeks and exclude people with important medical conditions. Absence of a problem during a short trial does not establish safety over years or in a broader population.

Graded, dried Withania Somnifera roots (Ashwagandha Roots)
Ashwagandha Roots1 · Piyush Kothari · CC BY-SA 4.0 · Source · License

What a large recent trial adds

A 2026 multicenter randomized double-blind placebo-controlled study enrolled 1,002 adults with reported stress and anxiety. Participants received 600 milligrams per day of a specific ashwagandha root extract or placebo for eight weeks. Serious adverse events were not reported, and laboratory markers, including liver tests, did not differ meaningfully between groups.

The large sample and prospective monitoring are useful. Still, the trial evaluated one extract for eight weeks in selected adults. It was not designed to exclude extremely rare events, establish long-term safety, or compare root-only products with leaf-containing or higher-concentration extracts.

Another recent randomized study using 300 milligrams twice daily for 24 weeks reported mild events such as nausea, abdominal pain, and drowsiness in some participants. Product-specific trials can inform expectations, but consumers should avoid combining their most favorable results into a blanket guarantee for the entire category.

Rare liver injury changes the risk discussion

NCCIH notes that a number of cases have linked ashwagandha supplements with liver injury, although the event appears rare. Case reports cannot always prove causation, and contamination or co-used products can complicate attribution. They remain important because serious uncommon harms may not appear in ordinary-sized randomized trials.

Stop the product and seek medical care for yellowing of the skin or eyes, dark urine, pale stool, unusual itching, persistent nausea or vomiting, marked fatigue, or right-upper-abdominal pain. Continuing a supplement while waiting to see whether those signs pass can increase risk.

Gastrointestinal symptoms alone are more often benign, but timing is informative. Record when the product started, the dose, meals, other new supplements, and when symptoms resolve after stopping. Rechallenge is not a safe home experiment when liver injury or a serious allergic reaction is possible.

Withania somnifera , South Africa
Withania somnifera SA · botaneek · CC BY-SA 4.0 · Source · License

Who should be especially cautious

NCCIH advises avoiding ashwagandha during pregnancy and says it should not be used while breastfeeding. It is not recommended for people about to have surgery or those with autoimmune or thyroid disorders. Potential interactions include diabetes and blood-pressure medicines, immunosuppressants, sedatives, anti-seizure medicines, and thyroid hormone.

Choose a product that states plant part, extract amount, and standardization, with independent quality testing when available. Avoid proprietary blends that hide the dose and multi-ingredient formulas that make an adverse effect difficult to trace. Do not stack several sedating sleep products without professional review.

A reasonable short-term experiment still needs a defined goal, baseline symptom measure, and stop rule. Record sleep or stress consistently rather than judging the product from one unusually good or bad day. If there is no meaningful improvement within the period supported by the product's evidence, increasing the dose or extending use indefinitely adds uncertainty rather than proof. If stress, anxiety, or insomnia is severe or persistent, a supplement should not delay evidence-based care. The practical question is not whether ashwagandha is universally safe or dangerous; it is whether a specific, identifiable product offers a worthwhile, monitored tradeoff for a specific person.

Sources & further reading

  1. NCCIH: Ashwagandha—Usefulness and Safety ↗
  2. 2026 randomized multicenter ashwagandha safety trial ↗
  3. Randomized 24-week ashwagandha trial in adults with stress ↗

This article provides educational information. Ask a qualified clinician or pharmacist about your symptoms, medical conditions, medicines and supplement interactions.

More on Sleep & Stress →